
£3,474.99 GBP inc. VAT
The NIOX VERO® device offers a non-invasive, user-friendly approach for quick and standardized FeNO assessments. It serves as a point-of-care tool for evaluating airway inflammation in individuals with respiratory issues. With over 45 million tests conducted globally, healthcare providers utilize this system to enhance asthma management by supporting:
- Diagnosis
- Evaluating response to inhaled corticosteroids
- Customizing inhaled steroid usage
- Tracking treatment adherence
- Lowering the risk of exacerbations in vulnerable patients compared to conventional monitoring
- FeNO testing is now globally recommended in asthma management guidelines.
Effortless and intuitive The NIOX VERO® is designed to make FeNO testing as easy as breathing. It aids in diagnosing patients, optimizing treatment, minimizing exacerbations, and identifying non-compliance with Inhaled Corticosteroids (ICS), all in a single breath. Created with user convenience in mind, NIOX VERO® provides everything necessary for FeNO testing and more:
- Patient ID: Keep track of patient progress with the integrated identification feature.
- Interactive Animations: Simplify FeNO measurement for patients with engaging animations. Three animations with sound effects guide patients to a successful test.
- Breathing Handle: The unique breathing handle makes testing as simple as inhaling and exhaling.
- Exhalation Modes: With two exhalation modes (6-second and 10-second), FeNO testing is accessible to everyone, from children aged 4 to patients with significantly reduced lung function.
- Failsafe Testing: NIOX® ensures patients do not fail a test. Flow Rate Control™ assists patients in maintaining a steady exhalation throughout the test, ensuring accurate results every time.
Onscreen Testing Guidance:
The NIOX VERO® offers excellent repeatability and reproducibility, allowing for successful measurements in a single test. The device is equipped with unique technology to ensure accurate results every time. NIOX® is the only device in Europe and the United States fully compliant with ER